Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06262594
PHASE3
Lemborexant Treatment of Insomnia Linked to Epilepsy
Sponsor: University of Manitoba
View on ClinicalTrials.gov
Summary
The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
26
Start Date
2024-10-29
Completion Date
2027-04-18
Last Updated
2025-02-13
Healthy Volunteers
No
Interventions
DRUG
Lemborexant
Drug is administered
DRUG
Placebo
Drug is administered
Locations (2)
Duke University
Durham, North Carolina, United States
Health Sciences Centre
Winnipeg, Manitoba, Canada